Fuller Smith & Turner (FSTA)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 794.00 |
|---|---|
| 52-week range | 588.00 – 818.00 |
| Return, 1 month / 3 months | +13.8% / +4.5% |
| Return, 1 year / 3 years | +34.6% / +50.6% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 29.4% |
| Worst drawdown (1 year) | -17.3% |
| Average daily value traded | 28.26M GBX |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Fuller Smith & Turner is a British brewer and pub operator based in London. It brews beer at its Griffin Brewery in Chiswick, including its London Pride ale, and runs a large estate of pubs and inns, many of them in southern England. Its pubs serve food and drink to local customers and travellers, and several of its sites offer overnight accommodation. The company also supplies its beers to other pubs and retailers.
On this site Fuller Smith & Turner appears as a stock on the London Stock Exchange (UK), code FSTA, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Fuller Smith & Turner (FSTA) trades on the London Stock Exchange in UK. It last closed at GBX 794.00 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 254 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.6% and over the last three months it rose 4.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.0% | ||
| From 52-week high | -1.0% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.5% | ||
| 6-month return | 25.2% | ||
| 12-month return, skipping the last month | 18.3% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.3% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 28.26M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | +13.8% |
| 3 months | +4.5% |
| 6 months | +25.2% |
| 1 year | +34.6% |
| 3 years | +50.6% |
| 5 years | +32.5% |
Signals
| 50-day / 200-day average | 729.36 / 696.53 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 26.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jul 2026 | GBP 0.1335 |
| 11 Dec 2025 | GBP 0.0785 |
| 3 Jul 2025 | GBP 0.1235 |
| 12 Dec 2024 | GBP 0.0741 |
| 4 Jul 2024 | GBP 0.1112 |
| 14 Dec 2023 | GBP 0.0663 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.